Hereditary Cancer Testing for Colorectal Cancer and Uterine (Endometrial) Cancer

COLARIS® is a genetic test that assesses a person’s risk of developing hereditary colorectal cancer and a woman’s risk of developing hereditary uterine (endometrial) cancer. Using a simple blood test or oral rinse sample, COLARIS® detects disease-causing mutations in the MLH1, MSH2, EPCAM, MSH6, PMS2 and MYH genes that are responsible for the majority of Lynch syndrome and MYH-associated polyposis (MAP) cases.

Myriad has developed a Hereditary Cancer Quiz that patients and physicians can use to help identify potential candidates for genetic testing using COLARIS.

Learn More

Recommended Links